Essential Oils on Anxiety of Patients Suffering From Cancer

Neoplasm Metastasis Clinical Trial

— RHECAP  

Official title:

Impact of Essential Oils on Anxiety of Patients Suffering From Metastasis Cancer - Feasibility Study

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02835352
• Other study ID #: 2014-AH-DOUL-SC
• Status: Terminated
• Phase: N/A
• First received: July 11, 2016
• Last updated: January 23, 2018
• Start date: June 21, 2016
• Est. completion date: May 1, 2017

Study information

• Verified date: January 2018
• Source: Center Eugene Marquis
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study evaluates the impact of essential oils massage on anxiety of patients who are suffering from cancer at a metastasis stage. Half of patients will be massaged first by essential oils and then by oil only. The other half will be massaged first by oil and then by essential oils.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 29
• Est. completion date: May 1, 2017
• Est. primary completion date: May 1, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Adult suffering from cancer at a metastatic stage

• Life expectancy > 15 days, assessed by investigator

• Hospitalized at the Chevrel unit from Centre Eugène Marquis, palliative unit care, for more than 15 days

• Regular anxiolytic treatment or imperative need to introduce anxiolytic treatment (assessed by investigator) within 48 hours following his hospitalization entry

• > 18 years

Exclusion Criteria:

• Patient already recruited in a therapeutic trial

• Patient not covered by a social security system

• Pregnant or likely pregnant patient, breastfeeding patient

• Allergy to any component of essential oils mixture and vegetable oils : bitter orange petitgrain, fine lavender, ylang-ylang, macadamia

• Minors, people deprived of their liberty or protected people,

• Impaired cognitive functions making impossible to obtain informed consent

Related Conditions & MeSH terms

• Neoplasm Metastasis

Intervention

Other:
• Essential oils massages

• Oil massages

Locations

Country	Name	City	State
France	Centre Eugène Marquis	Rennes

Sponsors (1)

Lead Sponsor	Collaborator
Center Eugene Marquis

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Anxiolytic consumption	Anxiolytic consumption will be assessed at day 7 at the end of each phase	7 days